Long COVID Cutaneous Signatures: An ARPA Funded Research Project
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• 1\. Long COVID defined by NIH PASC criteria OR 2. Acute COVID who tested positive for COVID without persistent symptoms OR 3. Postural orthostatic tachycardia syndrome (POTS) OR 4. Diabetic neuropathy
Locations
United States
Arizona
CND Life Sciences
RECRUITING
Scottsdale
Contact Information
Primary
Aracely Galarza
clinicalresearch@cndlifesciences.com
480-434-6446
Time Frame
Start Date: 2023-11-30
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 300
Treatments
Long COVID
Participants with Long COVID
Acute COVID
Participants with acute COVID who tested positive for COVID without persistent symptoms
Postural Orthostatic Tachycardia Syndrome (POTS)
Participants with postural orthostatic tachycardia syndrome (POTS)
Diabetic neuropathy
Participants with diabetic neuropathy
Related Therapeutic Areas
Sponsors
Leads: CND Life Sciences